195 related articles for article (PubMed ID: 18378164)
21. Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection.
Zhu D; Jiang S; Luo X
Vaccine; 2005 Aug; 23(37):4619-24. PubMed ID: 16053938
[TBL] [Abstract][Full Text] [Related]
22. Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis.
Aagaard CS; Hoang TT; Vingsbo-Lundberg C; Dietrich J; Andersen P
J Immunol; 2009 Aug; 183(4):2659-68. PubMed ID: 19620314
[TBL] [Abstract][Full Text] [Related]
23. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
[TBL] [Abstract][Full Text] [Related]
24. Superexpression of tuberculosis antigens in plant leaves.
Dorokhov YL; Sheveleva AA; Frolova OY; Komarova TV; Zvereva AS; Ivanov PA; Atabekov JG
Tuberculosis (Edinb); 2007 May; 87(3):218-24. PubMed ID: 17182283
[TBL] [Abstract][Full Text] [Related]
25. Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis.
Zhu Bd; Qie Yq; Wang Jl; Zhang Y; Wang Qz; Xu Y; Wang Hh
Eur J Pharm Biopharm; 2007 Jun; 66(3):318-26. PubMed ID: 17280823
[TBL] [Abstract][Full Text] [Related]
26. Expression and purification of immunologically reactive DPPD, a recombinant Mycobacterium tuberculosis skin test antigen, using Mycobacterium smegmatis and Escherichia coli host cells.
Liu C; Flamoe E; Chen HJ; Carter D; Reed SG; Campos-Neto A
Can J Microbiol; 2004 Feb; 50(2):97-105. PubMed ID: 15052311
[TBL] [Abstract][Full Text] [Related]
27. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
Fan X; Gao Q; Fu R
Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
[TBL] [Abstract][Full Text] [Related]
28. [Construction of recombinant Mycobacterium smegmatis expressing ESAT-6 and its effects on macrophages].
Li Y; Bao L; Zhang HD; Li YS; Zhu HL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):923-6. PubMed ID: 16864078
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57/BL6 mice.
Qie YQ; Wang JL; Zhu BD; Xu Y; Wang QZ; Chen JZ; Wang HH
Scand J Immunol; 2008 Feb; 67(2):133-9. PubMed ID: 18201368
[TBL] [Abstract][Full Text] [Related]
30. Expression of tuberculosis antigen ESAT-6 in Nicotiana tabacum using a potato virus X-based vector.
Zelada AM; Calamante G; de la Paz Santangelo M; Bigi F; Verna F; Mentaberry A; Cataldi A
Tuberculosis (Edinb); 2006; 86(3-4):263-7. PubMed ID: 16644283
[TBL] [Abstract][Full Text] [Related]
31. Recombinant antigen production for assays of intradermoreaction for diagnosis and surveillance of tuberculosis.
Malaghini M; Thomaz-Soccol V; Probst CM; Krieger MA; Preti H; Kritski A; Soccol CR
J Biotechnol; 2011 Oct; 156(1):56-8. PubMed ID: 21810448
[TBL] [Abstract][Full Text] [Related]
32. Improved cellular immune response elicited by a ubiquitin-fused DNA vaccine against Mycobacterium tuberculosis.
Wang Q; Lei C; Wan H; Liu Q
DNA Cell Biol; 2012 Apr; 31(4):489-95. PubMed ID: 21905875
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapeutic potential of recombinant ESAT-6 protein in mouse model of experimental tuberculosis.
Mir SA; Verma I; Sharma S
Immunol Lett; 2014; 158(1-2):88-94. PubMed ID: 24345702
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
35. [Construction and expression of the prokaryotic expression vector of MTB cfpl0-esat6 fusion gene].
Li H; Chen J; Liu G; Yao W; Yang J; Liu Y; Zeng L; Tian Y; Wang T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Jun; 24(3):636-40. PubMed ID: 17713278
[TBL] [Abstract][Full Text] [Related]
36. Identification of the new T-cell-stimulating antigens from Mycobacterium tuberculosis culture filtrate.
Lim JH; Kim HJ; Lee KS; Jo EK; Song CH; Jung SB; Kim SY; Lee JS; Paik TH; Park JK
FEMS Microbiol Lett; 2004 Mar; 232(1):51-9. PubMed ID: 15019734
[TBL] [Abstract][Full Text] [Related]
37. Recombinant adenovirus delivery of calreticulin-ESAT-6 produces an antigen-specific immune response but no protection against a Mycobacterium tuberculosis challenge.
Esparza-González SC; Troy A; Troudt J; Loera-Arias MJ; Villatoro-Hernández J; Torres-López E; Ancer-Rodríguez J; Gutiérrez-Puente Y; Muñoz-Maldonado G; Saucedo-Cárdenas O; Montes-de-Oca-Luna R; Izzo A
Scand J Immunol; 2012 Mar; 75(3):259-65. PubMed ID: 22010821
[TBL] [Abstract][Full Text] [Related]
38. [Constructing shuttle plasmid fusion expressing Ag85B-ESAT-6 on the surface of Mycobacterium].
Shi CH; Fan XL; Shi JR; Xu ZK; Li Y; Bai YN; Xun Y
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):249-52. PubMed ID: 15144616
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of secretory proteins Rv3619c and Rv3620c from Mycobacterium tuberculosis H37Rv.
Mahmood A; Srivastava S; Tripathi S; Ansari MA; Owais M; Arora A
FEBS J; 2011 Jan; 278(2):341-53. PubMed ID: 21134129
[TBL] [Abstract][Full Text] [Related]
40. Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice.
Kalra M; Grover A; Mehta N; Singh J; Kaur J; Sable SB; Behera D; Sharma P; Verma I; Khuller GK
Clin Immunol; 2007 Nov; 125(2):173-83. PubMed ID: 17766185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]